Last reviewed · How we verify
NCT04336878: HHIPBe
Healthy Habits in Pregnancy and Beyond
NA trial testing Healthy Habits in Pregnancy and Beyond in Overweight and Obesity in 25 participants. Completed in 25 September 2022.
25 September 2022
Quick facts
| Lead sponsor | Queen's University, Belfast |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | prevention |
| Enrollment | 25 |
| Start date | 1 March 2021 |
| Primary completion | 25 September 2022 |
| Estimated completion | 25 September 2022 |
| Sites | 1 location across United Kingdom |
Drugs / interventions tested
- Healthy Habits in Pregnancy and Beyond
Conditions studied
- Overweight and Obesity — all drugs for Overweight and Obesity →
- Pregnancy Related — all drugs for Pregnancy Related →
Sponsor
Queen's University, Belfast
Who can join
18 and older, female only, with Overweight and Obesity or Pregnancy Related. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
More than 50% of pregnant women are considered to have a BMI that is classified as overweight or obese when they present for antenatal care. Overweight and obesity in pregnancy is associated with complications and poorer health outcomes for mothers and their babies, as well as risk for excessive gestational weight gain and postpartum weight retention, increasing the likelihood of long-term obesity for these women. There is also evidence that excess maternal weight and weight gain in pregnancy is associated with obesity in the offspring from early childhood through to adolescence. There is an urgent need for simple, effective interventions targeting lifestyle which can be delivered during routine healthcare. The overall aim of this study is to pilot test the delivery of a brief, habit-based weight management intervention, 'Healthy Habits In Pregnancy and Beyond', for pregnant women with overweight and obesity (body mass index between 25.0 \& \<38.0 kg/m2) in early pregnancy, to gather preliminary information on the intervention and to establish the feasibility and acceptability of delivering this intervention into routine antenatal care and existing antenatal care pathways across four geographical locations in Northern Ireland and the Republic of Ireland. This study is a two-arm randomised controlled feasibility study. Healthcare staff in four partner sites will be trained in introducing the study to the target sample and in delivering the intervention. 80 women will be recruited and randomised to control (n=40) or intervention group (n=40) (20 at each site). Women randomised to the intervention group will receive a brief intervention to encourage the development of ten healthy habits in relation to diet, physical activity and weight management, plus their local routine antenatal care. The intervention will be delivered by a designated midwife at each site or a member of the research team, and is aimed to be integrated into appointments already attended by women as part of routine antenatal care. Women randomised to the control group will receive their local routine antenatal care.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Development of a habit-based intervention to support healthy eating and physical activity behaviours for pregnant women with overweight or obesity: Healthy Habits in Pregnancy and Beyond (HHIPBe).
McClelland J, Gallagher D, Moore SE, McGirr C, et al · · 2024 · cited 1× · PMID 39550532 · DOI 10.1186/s12884-024-06945-7 -
Development of a habit-based intervention to support healthy eating and physical activity behaviours for pregnant women with overweight or obesity: Healthy Habits in Pregnancy and Beyond (HHIPBe)
McClelland J, Gallagher D, Moore SE, McGirr C, et al · · 2024 · DOI 10.21203/rs.3.rs-3759776/v1
Verify or expand the search:
- PubMed search for NCT04336878
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Overweight and Obesity
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07406191 — WB-EMS Effects on Cardiometabolic Risk Factors · NA · recruiting
- NCT07230496 — A Study to Investigate Safety, Tolerability and Pharmacokinetics of LAE103 or LAE103 in Combination With LAE102 in Healt · Phase 1 · recruiting
- NCT07313761 — A Trial to Compare the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered · Phase 1 · active not recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Other Queen's University, Belfast trials
Trials by the same sponsor.
- NCT07373041 — Heart Failure Carer Support Programme: Implementation Testing in the UK. · NA · not yet recruiting
- NCT07482839 — Feasibility Study of a Compassionate Mindful Resilience (CMR) Intervention to Improve Mental Health Well-being Outcomes · NA · not yet recruiting
- NCT07333924 — Randomised Study Within a Review (SWAR) to Compare Communication of the Findings of Systematic Reviews to the Public by · Phase 3 · completed
- NCT06896799 — Determining the Effect of Food Ordering on Blood Glucose In Gestational Diabetes Mellitus (DEFI-GDM) · NA · recruiting
- NCT06749327 — Dissecting the Roles of High-quality Diets and Ultra Processed Foods on Cardiometabolic Health · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04336878 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Queen's University, Belfast
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04336878.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing